Table 3

Observed hepatitis C virus (HCV) antibody prevalence rates for male 16–49 year olds in five year age bands undergoing, or eligible to undergo, surgery

Cardiothoracic/ cardiologyOrthopaedics/ rheumatologyGeneral surgery/ENTTotal (prevalence %)
16–19 years
    Tested113767115
    Positive001 1 (0.9%)
20–24 years
    Tested305574159
    Positive013 4 (2.5%)
25–29 years
    Tested5712092269
    Positive379 19 (7.1%)
30–34 years
    Tested81150135366
    Positive71522 44 (12.0%)
35–39 years
    Tested160175145480
    Positive525 12 (2.5%)
40–44 years
    Tested248226166640
    Positive3105 18 (2.8%)
45–49 years
    Tested298204174676
    Positive122 5 (0.7%)